SofWave Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Public

  • Employees
  • 151

Employees

  • Stock Symbol
  • SOFW

Stock Symbol

  • Share Price
  • $10.95
  • (As of Friday Closing)

SofWave General Information

Description

Sofwave Medical Ltd is engaged in the development, production, marketing, and sale of systems for skin rejuvenation and firming treatments. SUPERB, Synchronous Ultrasound Parallel Beam technology, is the company's FDA-cleared technology to improve facial lines and wrinkles, lift the eyebrows and lax submental tissue (beneath the chin), lift lax skin in the arms, and provide short-term improvement in the appearance of cellulite and treatment of acne scars. Its Pure Impact module uses EMS technology and is cleared for muscle toning. Sofwave's products provide physicians with effective and safe aesthetic solutions for their patients. Geographically, it generates maximum revenue from the United States, followed by East Asia, Europe and the Middle East, and other regions.

Contact Information

Website
www.sofwave.com
Formerly Known As
ArchiMedUS Medical
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 1 Ha-Otsma Street
  • Yokneam Illit
  • Israel
+972
Primary Industry
Other Devices and Supplies
Stock Exchange
TAE
Vertical(s)
Corporate Office
  • 1 Ha-Otsma Street
  • Yokneam Illit
  • Israel
+972

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

SofWave Stock Performance

As of 13-Nov-2026, SofWave’s stock price is $10.95. Its current market cap is $398M with 36.4M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$10.95 $11.32 $8.28 - $16.77 $398M 36.4M 95.3K $0.33

SofWave Financials Summary

As of 30-Sep-2026, SofWave has a trailing 12-month revenue of $112M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 394,213 284,163 120,578 105,006
Revenue 111,775 87,637 59,651 50,315
EBITDA 13,458 6,940 (2,895) (7,390)
Net Income 11,976 5,487 (4,546) (8,278)
Total Assets 65,988 55,769 43,029 43,536
Total Debt 1,253 1,124 1,395 1,329
Public Fundamental Data provided by Morningstar, Inc. disclaimer

SofWave Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore SofWave‘s full profile, request access.

Request a free trial

SofWave Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore SofWave‘s full profile, request access.

Request a free trial

SofWave Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Sofwave Medical Ltd is engaged in the development, production, marketing, and sale of systems for skin rejuvenation and
Other Devices and Supplies
Yokneam Illit, Israel
151 As of 2025

Raleigh, NC
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

SofWave Competitors (1)

One of SofWave’s competitors is Ultherapy, a Corporation company based in Raleigh, NC.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Ultherapy Corporation Raleigh, NC
You’re viewing 1 of 1 competitors. Get the full list »

SofWave Patents

SofWave Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-D1120866-S1 Charging station for electronic muscle stimulator Active 08-Jan-2024
US-D1084004-S1 Display screen with graphical user interface Active 08-Jan-2024
AU-2025206926-A1 Electrical muscle stimulation Pending 08-Jan-2024
WO-2025150044-A1 Electrical muscle stimulation Inactive 08-Jan-2024
US-D1121831-S1 Electronic muscle stimulator for medical purposes Active 08-Jan-2024
To view SofWave’s complete patent history, request access »

SofWave Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

SofWave ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Healthcare

Industry

Rank

Percentile

Medical Devices

Subindustry

Rank

Percentile

To view SofWave’s complete esg history, request access »

SofWave FAQs

  • When was SofWave founded?

    SofWave was founded in 2015.

  • Where is SofWave headquartered?

    SofWave is headquartered in Yokneam Illit, Israel.

  • What is the size of SofWave?

    SofWave has 151 total employees.

  • What industry is SofWave in?

    SofWave’s primary industry is Other Devices and Supplies.

  • Is SofWave a private or public company?

    SofWave is a Public company.

  • What is SofWave’s stock symbol?

    The ticker symbol for SofWave is SOFW.

  • What is the current stock price of SofWave?

    As of 13-Nov-2026 the stock price of SofWave is $10.95.

  • What is the current market cap of SofWave?

    The current market capitalization of SofWave is $398M.

  • What is SofWave’s current revenue?

    The trailing twelve month revenue for SofWave is $112M.

  • Who are SofWave’s competitors?

    Ultherapy is a competitor of SofWave.

  • What is SofWave’s annual earnings per share (EPS)?

    SofWave’s EPS for 12 months was $0.33.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process